Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for fibroblast growth factor- 23
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Prediction of Acute Kidney Injury by Fibroblast Growth Factor 23 (FGF-23) in Adult Patients, A Meta-…
- Modulation of fibroblast growth factor-23 expression and transepithelial calcium absorption in Caco-…
- Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
- Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery dise…
- Fibroblast Growth Factor 23 Level and Cardiovascular Parameters in Children with Chronic Kidney Dise…
Most Relevant Clinical Trials
- Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Trans…
- Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients
- Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Cathete…
- Low-Phosphate Diet and Fibroblast Growth Factor-23 Level
- Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23
